Patents by Inventor Sherif Abouelhadid

Sherif Abouelhadid has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Glycosylation method
    Patent number: 11278610
    Abstract: The invention relates to microbial host cells engineered to produce glycoconjugate vaccines by stable integration of an acceptor protein and an oligosaccharyltransferase into the host's genome, wherein expression of the oligosaccharyltransferase is regulated.
    Type: Grant
    Filed: March 17, 2020
    Date of Patent: March 22, 2022
    Assignee: London School of Hygiene and Tropical Medicine
    Inventors: Brendan Wren, Jon Cuccui, Sherif Abouelhadid
  • GLYCOSYLATION METHOD
    Publication number: 20200215178
    Abstract: The invention relates to microbial host cells engineered to produce glycoconjugate vaccines by stable integration of an acceptor protein and an oligosaccharyltransferase into the host's genome, wherein expression of the oligosaccharyltransferase is regulated.
    Type: Application
    Filed: March 17, 2020
    Publication date: July 9, 2020
    Applicant: London School of Hygiene and Tropical Medicine
    Inventors: Brendan Wren, Jon Cuccui, Sherif Abouelhadid
  • Glycosylation method
    Patent number: 10646562
    Abstract: The invention relates to microbial host cells engineered to produce glycoconjugate vaccines by stable integration of an acceptor protein and an oligosaccharyltransferase into the host's genome, wherein expression of the oligosaccharyltransferase is regulated.
    Type: Grant
    Filed: February 9, 2018
    Date of Patent: May 12, 2020
    Assignee: London School of Hygiene and Tropical Medicine
    Inventors: Brendan Wren, Jon Cuccui, Sherif Abouelhadid
  • GLYCOSYLATION METHOD
    Publication number: 20180169212
    Abstract: The invention relates to microbial host cells engineered to produce glycoconjugate vaccines by stable integration of an acceptor protein and an oligosaccharyltransferase into the host's genome, wherein expression of the oligosaccharyltransferase is regulated.
    Type: Application
    Filed: February 9, 2018
    Publication date: June 21, 2018
    Applicant: London School of Hygiene and Tropical Medicine
    Inventors: Brendan Wren, Jon Cuccui, Sherif Abouelhadid
  • Glycosylation method
    Patent number: 9931392
    Abstract: The invention relates to microbial host cells engineered to produce glycoconjugate vaccines by stable integration of an acceptor protein and an oligosaccharyltransferase into the host's genome, wherein expression of the oligosaccharyltransferase is regulated.
    Type: Grant
    Filed: January 17, 2014
    Date of Patent: April 3, 2018
    Assignee: London School of Hygiene and Tropical Medicine
    Inventors: Brendan Wren, Jon Cuccui, Sherif Abouelhadid
  • GLYCOSYLATION METHOD
    Publication number: 20150344928
    Abstract: The invention relates to microbial host cells engineered to produce glycoconjugate vaccines by stable integration of an acceptor protein and an oligosaccharyltransferase into the host's genome, wherein expression of the oligosaccharyltransferase is regulated.
    Type: Application
    Filed: January 17, 2014
    Publication date: December 3, 2015
    Applicant: London School of Hygiene and Tropical Medicine
    Inventors: Brendan Wren, Jon Cuccui, Sherif Abouelhadid